Targeting cannabinoid receptor 2 (CB2) limits collagen production—An in vitro study in a primary culture of human fibroblasts

Inês Correia‐Sá,Cláudia Carvalho,Vera A. Machado,Sofia Carvalho,Paula Serrão,Marisa Marques,Maria A. Vieira‐Coelho
DOI: https://doi.org/10.1111/fcp.12716
2021-08-19
Fundamental and Clinical Pharmacology
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Previous studies showed that cannabinoid 2 (CB2) receptor is involved in skin inflammation, fibrogenesis and re-epithelialization in mice, indicating that this receptor may be implicated in wound healing. Thus, topical use of cannabinoids may have a role in local fibrotic and wound healing diseases such as scars or keloids. We investigate the effect of the CB2 selective receptor agonist (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (JWH133) and the CB2 selective receptor antagonist (6-Iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl)(4-methoxyphenyl)-methanone (AM630), on primary cultures of human fibroblasts.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Material and Methods</h3><p>Primary cultures of adult human fibroblasts were obtained from abdominal human skin samples. Fibroblasts pretreated with JWH133 and/or AM630 were stimulated with TGF-<i>β</i> (10 ng/mL). Fibroblast activation into myofibroblasts was quantified by the expression of alpha-smooth muscle actin (<i>α</i>-SMA) using Immunocytochemistry and Western Blot assays. Collagen content was quantified with the Sirius red staining assay. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Upon human fibroblasts stimulation with TGF-<i>β,</i> a significant increase on <i>α</i>-SMA and CB2 receptor expression was observed. In these cells, JWH133 decreased <i>α</i>-SMA expression and collagen content. However, this effect was not observed in resting human fibroblasts. AM630 decreased <i>α</i>-SMA expression and collagen content in both resting and activated fibroblasts. This effect was time- and concentration-dependent with an IC<sub>50</sub> value of 11 μM. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>The CB2 receptor appears to be involved in fibroblast repair during skin wound healing in humans, as TGF-<i>β</i> increases CB2 receptor expression and JWH133 produces an anti-fibrotic effect in human fibroblasts. AM630 also showed an anti-fibrotic effect hypothesizing that other cannabinoid receptors, such as TRPV, may be involved in this response. </p></section>
pharmacology & pharmacy
What problem does this paper attempt to address?